Taylor v. Wexford Health Sources, Incorporated

District Court, S.D. West Virginia·Decided June 21, 2024·No. 2:23-cv-00475·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF WEST VIRGINIA

CHARLESTON DIVISION

JOSEPH TAYLOR,

Plaintiff,

v. CIVIL ACTION NO. 2:23-cv-00475

WEXFORD HEALTH SOURCES, INCORPORATED, et al.,

Defendants.

MEMORANDUM OPINION AND ORDER

The Court has reviewed several motions in limine filed by each party in this matter, and provides the rulings set forth below. DEFENDANTS’ MOTIONS 1. Document 212 The Court has reviewed the Defendants’ Joint Motion in Limine to Preclude Plaintiff’s Argument, Theory of Case, or Testimony Asserting that the Defendants’ MOUD Policy Was “If You Did Not Have An Active MOUD Prescription At the Time of Incarceration, Then You Were Precluded from Receiving MOUD Treatment (Document 212) and the Plaintiff’s Consolidated Response to Defendants’ Joint Motions in Limine 1-8 (Document 227) (hereinafter, Pl.’s Resp.). The Defendants argue that the evidence establishes that Wexford’s guidelines for treatment of OUD (opioid use disorder) called for an individualized approach, and providers could start MOUD (medication for opioid use disorder) for a patient who did not have an active prescription on intake if the provider believed it to be medically indicated. Therefore, they request that the Court preclude the Plaintiff from arguing or introducing testimony that the Defendants’ policy was to provide MOUD only if patients arrived with an active prescription. The Plaintiff argues that the Defendants seek to improperly relitigate the motions for

summary judgment and ask the Court to resolve a factual dispute, rather than an evidentiary issue, through this motion in limine. The Court finds that the motion seeks resolution of a disputed factual issue, as more fully discussed in the Court’s opinion resolving the motions for summary judgment. Therefore, the Court ORDERS that Defendants’ Joint Motion in Limine to Preclude Plaintiff’s Argument, Theory of Case, or Testimony Asserting that the Defendants’ MOUD Policy Was “If You Did Not Have an Active MOUD Prescription at the Time of Incarceration, Then You Were Precluded from Receiving MOUD Treatment (Document 212) be DENIED. 2. Documents 213 and 218 The Court has reviewed the Defendants’ Joint Motion in Limine to Preclude Lay Witnesses

from Offering Medical Opinions at Trial (Document 213), the Defendants’ Joint Motion in Limine to Preclude Any Testimony or Argument That Plaintiff Overdosed After He Was Released from Central Regional Jail (Document 218) and the Plaintiff’s Response. The Defendants argue that some of the Plaintiff’s statements in his deposition, such as his testimony that he was withdrawing from Suboxone when he was admitted to CRJ (Central Regional Jail) and that he overdosed on opioids following his release, require medical expertise. They also contend that the Plaintiff’s expert lacks a sufficient basis to testify regarding the Plaintiff’s alleged overdose.

2 The Plaintiff argues that the rules permit him to testify as to his own experiences in going through withdrawal and suffering an overdose, and also permit his wife to testify about observing his overdose and reviving him. He emphasizes that the proposed testimony would be based on the witnesses’ personal knowledge, and recognizing symptoms of drug overdose is within the

knowledge of a lay person. The Plaintiff further argues that Dr. Fingerhood’s opinion is adequately supported, and that Dr. Mitcheff’s declaration, dated May 10, 2024, should be stricken because it is untimely, covers a subject that was not properly disclosed pursuant to Rule 26(a)(2), does not satisfy Rule 702, lacks supporting methodology and citations, and would cause prejudicial surprise. The Court finds that the Plaintiff and other witnesses should be permitted to testify as to their own experiences and matters within their personal knowledge, including withdrawal and overdose. Withdrawal and overdose are within the knowledge of laypeople, particularly laypeople with a history of OUD or a close relationship with someone with OUD. Any objections as to foundation can be made during trial, and the Defendants may challenge testimony on cross-

examination. The Court would note, however, that such testimony must be limited to that within the knowledge of the witnesses. The Plaintiff has referred to the alleged overdose, for which he did not receive professional medical care, as “near-fatal,” which, absent further evidence establishing a foundation, may be outside the scope of knowledge of a layperson. Following careful consideration, the Court ORDERS that the Defendants’ Joint Motion in Limine to Preclude Lay Witnesses from Offering Medical Opinions at Trial (Document 213) and the Defendants’ Joint Motion in Limine to Preclude Any Testimony or Argument That Plaintiff Overdosed After He Was Released from Central Regional Jail (Document 218) be DENIED.

3 3. Document 214 The Court has reviewed the Defendants’ Joint Motion in Limine to Preclude Plaintiff from Arguing at Trial That Defendants Maintain a Policy of Not Prescribing Medications for Opioid Use Disorder in Order to Save Money (Document 214) and the Plaintiff’s Response. The

Defendants argue that “[t]here is no evidence to support the allegations that Defendants financially benefit by not providing inmates with MOUD and therefore force inmates with OUD, including those already being treated with MOUD, into withdrawal.” (Defs.’ Mot. at 3) (Document 214.) The Plaintiff concurs in this motion and contends that the Defendant should likewise be precluded from introducing evidence or argument regarding the financial motivations underlying the defendants’ MOUD policies. Accordingly, the Court ORDERS that the Defendants’ Joint Motion in Limine to Preclude Plaintiff from Arguing at Trial That Defendants Maintain a Policy of Not Prescribing Medications for Opioid Use Disorder in Order to Save Money (Document 214) be GRANTED as unopposed. 4. Document 215

The Court has reviewed the Defendants’ Joint Motion in Limine to Preclude Testimony That Plaintiff Was Withdrawing from Suboxone When He Entered Custody (Document 215) and the Plaintiff’s Response. The Defendants argue that the Plaintiff should not be able to testify as to what substance(s) caused his alleged withdrawal symptoms, and that his expert, Dr. Fingerhood, lacks a reliable basis for any testimony that he was in withdrawal from Suboxone as opposed to other substances. The Plaintiff contends that “the nature, cause, and severity of Mr. Taylor’s opioid withdrawal is a fact question that belongs to the jury.” (Pl.’s Resp. at 19.) He states that he does

4 not contend that his withdrawal symptoms were solely from the termination of Suboxone prescription, and withdrawal from multiple controlled substances does not preclude the admission of evidence that he suffered from Suboxone withdrawal. In addition, he argues that his years of experience with opioid use, treatment, and withdrawal provides a foundation for lay opinion

testimony regarding his experience. Ultimately, the Plaintiff contends that cross-examination, rather than exclusion, is the appropriate method of challenging the evidence regarding the Plaintiff’s alleged withdrawal from Suboxone. The Court finds that the factual dispute regarding the extent of Mr. Taylor’s withdrawal symptoms, the extent to which those symptoms were attributable to Suboxone, and whether MOUD should have been prescribed to alleviate those symptoms, cannot properly be resolved on a motion in limine. Therefore, the Court ORDERS that the Defendants’ Joint Motion in Limine to Preclude Testimony That Plaintiff Was Withdrawing from Suboxone When He Entered Custody (Document 215) be DENIED. 5. Document 216

Free access — add to your briefcase to read the full text and ask questions with AI

Taylor v. Wexford Health Sources, Incorporated, (S.D.W. Va. 2024).

Taylor v. Wexford Health Sources, Incorporated (Taylor v. Wexford Health Sources, Incorporated) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Deck v. Missouri
544 U.S. 622 (Supreme Court, 2005)